François M
Service ORL, Hôpital Robert-Debré, Paris.
Ann Pediatr (Paris). 1993 Sep;40(7):481-4.
The efficacy and safety of ear drops containing phenazone and lidocaine hydrochloride (Otipax) for the treatment of congestive myringitis were evaluated in 18 infants and children aged 1 to 10 years. Relief of pain was evident 5 minutes after instillation and significant after 15 to 30 minutes. Serial photographs of the tympanic membrane demonstrated prompt improvement of inflammation. Congestion was significantly reduced after five minutes and overall ear drum color was significantly improved after 15 to 30 minutes. No adverse effects were recorded. These data suggest that Otipax is effective and safe for the treatment of painful congestive myringitis in infants and children.
对18名年龄在1至10岁的婴幼儿使用含有非那宗和盐酸利多卡因的滴耳液(奥替哌克斯)治疗充血性鼓膜炎的疗效和安全性进行了评估。滴入后5分钟疼痛明显缓解,15至30分钟后显著缓解。鼓膜的系列照片显示炎症迅速改善。5分钟后充血明显减轻,15至30分钟后整个鼓膜颜色显著改善。未记录到不良反应。这些数据表明,奥替哌克斯治疗婴幼儿疼痛性充血性鼓膜炎有效且安全。